SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense post-earnings volatility as an unexpected CEO transition announcement overshadowed strong revenue and earnings results, fueling concerns about the firm's strategic direction in the AI era. While the community remains deeply divided between bargain hunters focusing on consistent fundamental growth and skeptics fearing that generative AI tools will erode the company's long-term competitive moat.

Trump For President

The TRUMP crypto token is currently trending as investors debate whether it acts as a genuine political expression or a high-risk pump-and-dump scheme. Community discussions are sharply divided, with supporters highlighting speculative potential and opposition pointing to its declining price action and intense political scrutiny.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as investors speculate on potential integration with Xs upcoming payments platform, driving anticipation for a major price move. The community remains polarized, with many users debating the coin's utility and long-term potential while actively monitoring technical breakout levels.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is facing intense volatility as the market debates its long-term growth prospects amid the broader software selloff and ongoing cybersecurity concerns. While investors are closely monitoring potential acquisition rumors and the firm's transition in financial leadership, the community remains divided over its valuation and the impact of AI on the cybersecurity competitive landscape.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is currently the center of investor discussion following the official rollout of its Eversense 365 integrated with the Twiist automated insulin delivery system, a milestone many view as a pivotal step in expanding its competitive footprint. While supporters highlight this product integration as a long-term growth catalyst, the community remains deeply divided, with many retail investors expressing frustration over the stock's recent price volatility and ongoing concerns regarding the company's long-term leadership and commercial execution.

Kyivstar Group Ltd. engages in the telecommunications and digital business. It provides mobile, digital and fixed-line services. The company was founded in 1994 and is headquartered in Dubai, United Arab Emirates.

Kyivstar Group Ltd.

Kyivstar Group is attracting significant community attention as investors view it as a primary pure-play proxy for Ukraine's economic recovery and potential peace negotiations. Discussions are heavily focused on the company's resilient fundamentals, recent Starlink direct-to-cell integration, and the speculative upside tied to geopolitical developments.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility driven by escalating geopolitical tensions in the Middle East and spiking oil prices, which have triggered broader market concerns about inflation and systemic financial stability. While some market participants are betting on a relief rally and Fed rate intervention, the community remains deeply divided, with active discussions focusing on algorithmic manipulation, high-risk oil supply chain disruptions, and the long-term impact of rising energy costs on tech-heavy valuations.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is garnering significant community attention as investors anticipate a major FDA milestone, with the company currently awaiting a crucial status update on its NDA submission. Discussions are heavily focused on the stock's low float, institutional accumulation, and the potential for a massive valuation shift driven by the upcoming U.S. patent and PDUFA catalysts.

Ulta Beauty, Inc. engages in the retail of beauty products. The company has one reportable segment, which includes retail stores, salon services, and e-commerce. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. The company was founded on January 9, 1990 and is headquartered in Bolingbrook, IL.

Ulta Beauty Inc

Ulta Beauty is trending following a strong quarterly earnings report that featured a revenue beat and upwardly revised guidance, driving significant investor interest. Despite the positive results, the stock is experiencing volatile price action as the community debates whether the company can maintain momentum amidst broader consumer spending concerns.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is facing intense volatility following a quarterly report that missed expectations and featured weaker-than-anticipated guidance, sparking a sharp sell-off. While some investors are betting on a recovery fueled by long-term growth in active users and ecosystem expansion, others are focused on concerns surrounding the upcoming lock-up expiration and the broader risks inherent in the buy-now-pay-later model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 12-Month High - Time to Buy?

Amicus Therapeutics (NASDAQ:FOLD) Hits New 12-Month High - Still a Buy...

Amicus Therapeutics (NASDAQ:FOLD) CEO Bradley Campbell Sells 22,500 Shares

Amicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) CEO Bradley Campbell sold 22,500 shares of the business's stock in a transaction on Monday, March 2nd. The shares were sold at an average...

Bradley Campbell Sells 22,500 Shares of Amicus Therapeutics (NASDAQ:FOLD) Stock

Amicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) CEO Bradley Campbell sold 22,500 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an...

JPMorgan Chase & Co. Has $16.68 Million Stock Position in Amicus Therapeutics, Inc. $FOLD

JPMorgan Chase & Co. reduced its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 4.3% in the 3rd quarter, according to the company in its most recent 13F filing with the...

Vanguard Group Inc. Buys 126,441 Shares of Amicus Therapeutics, Inc. $FOLD

Vanguard Group Inc. lifted its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 0.4% in the third quarter, according to the company in its most recent disclosure with the Securities...

William Blair Investment Management LLC Buys 1,107,083 Shares of Amicus Therapeutics, Inc. $FOLD

William Blair Investment Management LLC increased its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 7.6% during the third quarter, according to the company in its...

Fox Run Management L.L.C. Takes $553,000 Position in Amicus Therapeutics, Inc. $FOLD

Fox Run Management L.L.C. acquired a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The fund...

Primecap Management Co. CA Sells 128,200 Shares of Amicus Therapeutics, Inc. $FOLD

Primecap Management Co. CA cut its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 16.1% during the third quarter, according to its most recent 13F filing with the Securities and...

BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market

BioMarin beats Q4 earnings estimates as Voxzogo drives year-over-year revenue growth. The company decides to voluntarily withdraw its hemophilia gene therapy.

Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues

FOLD's Q4 earnings miss, but revenues beat estimates on strong Galafold and Pombiliti sales. The company is set to be acquired by BioMarin for $4.8 billion.

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Current Price	$14.37
Prev Close	$14.37
Open	$14.37
Dividend Yield	0.00%
50-Day Moving Average	$14.31
Beta	0.83
Avg. Volume	5.8M
PE Ratio	-162.19

52-Week High	$14.39
52-Week Low	$5.51
Market Capitalization	$4.51B
EPS (Annual)	-$0.0879
Price to Book	16.29
Revenue Per Employee	$1.24M

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FOLD News

FOLDAmicus Therapeutics Inc